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Evaluation of voltage-dependent 
calcium channel γ gene families 
identified several novel potential 
susceptible genes to schizophrenia
Fanglin Guan1,2,*, Tianxiao Zhang3,*, Xinshe Liu2,4, Wei Han1,2, Huali Lin5, Lu Li2, Gang Chen2 & 
Tao Li2,4
Voltage-gated L-type calcium channels (VLCC) are distributed widely throughout the brain. Among 
the genes involved in schizophrenia (SCZ), genes encoding VLCC subunits have attracted widespread 
attention. Among the four subunits comprising the VLCC (α − 1, α −2/δ, β, and γ), the γ subunit 
that comprises an eight-member protein family is the least well understood. In our study, to further 
investigate the risk susceptibility by the γ subunit gene family to SCZ, we conducted a large-
scale association study in Han Chinese individuals. The SNP rs17645023 located in the intergenic 
region of CACNG4 and CACNG5 was identified to be significantly associated with SCZ (OR = 0.856, 
P = 5.43 × 10−5). Similar results were obtained in the meta-analysis with the current SCZ PGC data 
(OR = 0.8853). We also identified a two-SNP haplotype (rs10420331-rs11084307, P = 1.4 × 10−6) 
covering the intronic region of CACNG8 to be significantly associated with SCZ. Epistasis analyses 
were conducted, and significant statistical interaction (OR = 0.622, P = 2.93 × 10−6, Pperm < 0.001) was 
observed between rs192808 (CACNG6) and rs2048137 (CACNG5). Our results indicate that CACNG4, 
CACNG5, CACNG6 and CACNG8 may contribute to the risk of SCZ. The statistical epistasis identified 
between CACNG5 and CACNG6 suggests that there may be an underlying biological interaction 
between the two genes.
Schizophrenia (SCZ) has a lifetime risk of approximately 1% and is a complex psychiatric disorder characterized 
by delusions, hallucinations, altered cognition, emotional reactivity and disorganized behavior1–3. Many epide-
miological studies and recent genetic studies of association mapping have suggested that genetic and gene–envi-
ronment interactions account for over 80% of the susceptibility of developing SCZ4,5. These studies have been 
accelerated by the widely used application of genome-wide association studies (GWASs) in SCZ6–10. To date, the 
Psychiatric Genomics Consortium (PGC) has published three mega-analyses on SCZ11–13. A recent multi-stage 
GWAS of SCZ by PGC demonstrated that 108 schizophrenia-associated loci met genome-wide significance in a 
sample of 36,989 cases and 113,075 controls, 83 of which have not been previously reported13. However, current 
replicable GWAS results account for only a small percentage of the estimated heritability14, and their systematic 
biological interpretation is lacking. Focusing on a specific GWAS-based variant might be misleading because the 
results of a GWAS contains many false positives15,16 and genetic heterogeneity of SCZ exists in different popula-
tions17. Thus, follow-up studies are essential to confirm the GWAS findings and extend them.
Voltage-gated L-type calcium channels (VLCC) are distributed widely throughout the brain and are critical 
for mediating intracellular Ca2 + influx in response to action potentials at the synapse. VLCCs have an impor-
tant role in N-methyl-d-aspartate (NMDA) receptor-independent synaptic plasticity processes18. Among the 
genes involved in SCZ, genes encoding VLCC subunits have attracted widespread attention. Recent GWASs 
have indicated that the CACNA1C gene, encoding an alpha-1 subunit of VLCC, is a susceptibility gene for 
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SCZ in individuals of European ancestry11–13. Our previous study has confirmed the association of CACNA1C 
with SCZ in a Han Chinese population19, and some neuroimaging studies have also documented the effects of 
CACNA1C variants on a range of structural and functional brain phenotypes, including the circuitry involved 
in emotion processing, executive function, attention and memory20–22. However, among the four subunits com-
prising the mammalian VLCC (alpha-1, alpha-2/delta, beta and gamma), the gamma subunit is the least well 
understood. The calcium channel gamma subunits comprise an eight-member protein family that shares a 
common topology consisting of four transmembrane domains and intracellular N- and C-termini. Some phy-
logenetic, bioinformatic and functional studies have indicated that they are a functionally diverse protein fam-
ily and that CACNG1-CACNG8 are all co-expressed in adult brains as an important mechanism for regulating 
Ca2+ channel function23,24. CACNG2 has been reported to be a susceptibility locus for SCZ in some popula-
tions25,26. However, given that some studies suggest an involvement of calcium-dependent regulatory processes in 
prefrontal-hippocampal network plasticity27,28 and the pathophysiology of SCZ20,21, it is still necessary to explore 
the potential association between common variants in the CACNG genes and SCZ. In the present study, to further 
investigate the risk of susceptibility to SCZ due to CACNG1-CACNG8, we conducted a large-sample association 
analysis in Han Chinese individuals.
Materials and Methods
Subjects. A total of 10,039 individuals, including 7521 healthy controls (3,903 females and 3,618 males; range 
of age 18–51 years; mean age 37.8 ± 9.6) and 2518 patients with SCZ (1,307 females and 1,211 males; range of age 
18–51 years; mean age 36.9 ± 9.3), were recruited for this study. All patients were recruited from the inpatient and 
outpatient clinical services of a psychiatric unit at the Xi’an Mental Health Center and were diagnosed by at least 
two experienced psychiatrists based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) cri-
teria for SCZ. All unrelated healthy controls were selected from a combination of local volunteers and blood trans-
fusion donors; those with a personal family history of mental illness in the previous three generations and with 
current or past evidence of psychoses were ruled out from the present study. All subjects enrolled from the city of 
Xi’an in Shaanxi Province were of Han descent, and we excluded anyone not born locally or whose immediate fam-
ily members from the previous three generations were not born locally. This research was performed in accordance 
with the ethical guidelines of the Declaration of Helsinki (version 2002) and was approved by the Medical Ethics 
Committee of Xi’an Jiaotong University. All participants completed written informed consent forms.
Genotyping. Because CACNG1, CACNG4 and CACNG5 are located next to each other on chromosome 17, 
we searched for all SNPs in the region covering the three genes with minor allele frequencies (MAF) > 0.05 
and heterozygosity (>0.2) in the HapMap Han Chinese in Beijing (CHB) population (Release 28). SNPs with 
pair-wise tagging and r2 ≥ 0.5 were used as the criteria when selecting tag SNPs in the LD blocks. The same 
criteria were used to select tag SNPs within CACNG6-8 on chromosome 19, CACNG2 on chromosome 22 and 
CACNG3 on chromosome 16. Given that the lengths of CACNG2 and CACNG3 are both more than 100 kb, 
we only selected the tag SNPs (tagging number > 3) in the LD blocks. Based on above criteria, a custom set of 
35 tag SNPs were finally selected in our study, and the distributions of these SNPs is shown in Supplementary 
Table S1. DNA was extracted from whole blood according to the standard protocol of the DNA Isolation Kit for 
Mammalian Blood (Tiangen Biotech Co., Ltd, Beijing, China). The DNA was stored at −80°C for genotyping. The 
genotyping was conducted for all of the SNPs using the Sequenom MassARRAY matrix-assisted laser desorption 
ionization-time of flight mass spectrometry platform (Sequenom, San Diego, CA, USA) on the genomic DNA 
isolated from the peripheral leukocytes. The final data were released using Typer Analyzer software. The reliabil-
ity of the subsequent statistical analysis was ensured, as the final genotype call rate of each SNP was greater than 
99.3% and the overall genotyping call rate was 99.5%. Additionally, 5% of random samples were repeated, and the 
results were 100% concordant.
Statistical analysis. Power analysis and quality control. We conducted a comprehensive power analy-
sis using Genetic Power Calculator29 based on our sample size and genotyped markers to estimate the statis-
tical power. The results are summarized in Supplemental Table S2. As shown in the table, for our sample size 
(10,039), we were able to achieve a statistical power greater than 80% to detect a common risk genetic variant 
that had an effect range from 1.2 to 1.3. Genetic markers that had an MAF greater than 0.05 and that passed the 
Hardy-Weinberg equilibrium test were included for further analysis.
Association Analysis. We performed both single-marker-based and haplotype-based analyses to detect 
the potential association signals between our genotyped SNPs and the SCZ disorder status. We conducted 
single-marker-based analysis by fitting a logistic model and the age and sex of the individuals were included 
in the model as two covariates to account for potential confounding effects. The SNPs were coded in three dif-
ferent models: additive, dominant and recessive. In the additive model, the individual’s genotype is coded as 0, 
1 and 2 when there are 0, 1 or 2 minor alleles. In the dominant model, the individual’s genotype is coded as 0 
when it is a homozygote of a major allele and 1 when it is a heterozygote or homozygote of a minor allele. In the 
recessive model, the individual’s genotype is coded as 1 when it is a homozygote of a minor allele and 0 other-
wise. The LD blocks were constructed using the default algorithm taken from Gabriel et al.30 We generated 95% 
confidence bounds on D’, and each comparison was called “strong LD” when the confidence bounds had an 
upper bound ≥ 0.98 and a lower bound ≥ 0.7. A block was created if 95% of the informative comparisons were 
“strong LD”. Plink31 was utilized for logistic model fitting, linkage disequilibrium (LD) blocks construction and 
haplotype-based association. A Bonferroni correction was performed to address the potential multiple compar-
ison problems.
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Epistasis Analysis. We conducted two-way epistasis analysis to detect the potential gene-by-gene interactions 
among the eight CACNG genes. Logistic models were fitted as shown in the following functions,
+ × + × + × + × + × +~logit (Y) b b SNP b SNP b SNP SNP b Age b Sex e0 1 A 2 B 3 A B 4 5
where Y is the SCZ disorder status. The test for interaction is based on the coefficient b3. Two covariates, sex and 
age, were added in the logistic model similar to the single-marker-based analysis. The SNP pairs were tested using 
the logistic model in an exhaustive way. Although SNP pairs located on the same chromosome were removed dur-
ing analysis, this method still produces a large number of statistical tests (432 tests in total). To reduce the inflated 
type I errors generated by multiple comparison, we performed 1,000 permutations by shuffling the case-control 
labels of our samples, and the null distribution was created by using the most significant P values in each permu-
tation cycle. The corrected P values for each SNP pair were calculated using this newly created null distribution to 
account for potential problems of multiple comparison. We utilized statistical computing software R32 to conduct 
this epistasis analysis.
Imputation and Meta-Analysis. We conducted imputation for a 1 Mb region around SNP rs17645023. We uti-
lized genetic software IMPUTE233 for the imputation and SNPTEST34 for the follow-up dosage data association 
test. The CHD + CHB HapMap3 dataset served as the reference data. The info metric was used as a method to 
remove poorly imputed SNPs from our association results. There is no universal cutoff value for post-imputation 
SNP filtering so we assessed different info thresholds by checking whether they produced sensible Q-Q plots 
(Supplemental Figure S1). We chose 0.4 as our info metric threshold by the Q-Q plots. In addition to the imputa-
tion analysis, we also conducted Meta-analysis for SNP rs17645023 using five GWAS datasets from the PGC. The 
R package meta35 was utilized for summarizing and virtualization of the meta-analysis.
Bioinformatics analysis. We examined the targeted SNPs and/or genes using several bioinformatics tools and 
databases. We utilized the protein-protein interaction database STRING (http://string-db.org/) to explore the 
potential interactions of our targeted genes. The Regulome DB (http://regulomedb.org/) was used to predict the 
potential functional consequences of the identified risk SNPs. This database is a web-based bioinformatics tool 
integrated with multiple types of data (including ChIP-seq, DNase-seq, and eQTLs) from the Encyclopedia of 
DNA Elements (ENCODE) project36.
Results
Association analysis. All of our genotyped SNPs passed our quality control criteria (Supplemental Table S3). 
The P value threshold for single-marker-based analysis was 0.001 (≈ 0.05/35). The SNP rs17645023 located on 
the intergenic region of CACNG5 and CACNG4 was identified to be significant in both the additive and domi-
nant models (Table 1). The genotype AA (or allele A) was significantly overrepresented in SCZ individuals. We 
also identified a significant protective effect of minor allele T in both the additive (OR = 0.86, P = 5.43 × 10−5) 
and dominant (OR = 0.85, P = 3.46 × 10−4) models. The full results of single marker based association analysis 
are summarized in Supplemental Table S4. Four LD blocks were constructed using our dataset. In the haplo-
type-based analysis, we found a two-SNP haplotype (rs10420331-rs11084307, P = 1.4 × 10−6) to be significantly 
associated with the SCZ disease status. This SNP pair covers the intronic region of gene CACNG8. The full results 
of haplotype analysis are summarized in Table 2.
Epistasis analysis. The two-way epistasis analysis included 432 SNP pairs, and the full results are sum-
marized in Supplemental Table S5. We identified significant statistical interaction (OR = 0.622, P = 2.93 × 10−6, 
Pperm < 0.001) between rs192808 (CACNG6) and rs2048137 (CACNG5) (Fig. 1). Both double homozygote GG-TT 
and double heterozygote GA-GT (rs192808-rs2048137) were overrepresented in control samples.
Imputation and Meta-Analysis. A total of 73 imputed SNPs passed our quality control criteria 
(info > 0.4). The full results of imputation association are summarized in Supplemental Table S6. No new sig-
nificant SNPs were identified with imputation analysis. The regional association plot based on both imputed and 
genotyped SNPs is shown in Fig. 2. The results of the meta-analysis are presented in Fig. 3, and the summarized 
result of the meta-analysis focused on rs17645023 was still significant with OR = 0.8853. The detailed information 
on the datasets used in the meta-analysis is summarized in Supplemental Table S7.
Bioinformatics Analysis. We explored the protein-protein interaction for the two genes with significant 
statistical epistasis evidence (CACNG5 and CACNG6) (Fig. 4). No direct evidence was found to support the 
protein-protein interaction between the two genes. The most related calcium channel voltage-dependent gamma 
subunits for CACNG6 are CACNG7 and CACNG8. Conversely, for CACNG5, the most related protein is encoded 
Genotype (n = 10,039)
Pallelic Padditive Pdominant PrecessiveAA (%) AT (%) TT (%)
SCZ (n = 2,518) 1,503 (59.7) 891 (35.4) 124 (4.9) 7.30 × 10−5 5.43 × 10−5 3.46 × 10−4 0.004
Controls (n = 7,521) 4,189 (55.7) 2,843 (37.8) 489 (6.5)
Table 1. The results of a single-marker-based association analysis for rs17645023. The significant results are 
highlighted in bold.
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by CACNG1. We investigated the potential functional consequences of rs17645023 in Regulome DB. This SNP 
has a Regulome DB score of 4, which means the potential biological function of this SNP is supported by both 
transcription factor (TF) binding and DNase peak data. The ChIP-seq data indicates that this SNP is located 
within the protein binding region of the transcription factor CEBPB in all three cell types (A549, HeLa-S3 and 
IMR90). In addition, rs17645023 is also located within the DNase hypersensitive region in all eight cell types 
(T47d, Sknmc, A549, Hvmf, Hpde6e6e7, Fibrop, Fibropag20443 and Fibrobl).
Discussion
One major finding in our study is the identification of a significant association between an intergenic SNP, 
rs17645023, and SCZ disease status. The potential association of this SNP with SCZ was first reported by Curtis 
et al. in 2011 using 523 SCZ cases and 505 controls with European ancestry (P < 10−6)37. The T allele at SNP 
rs17645023 is protective in both our study and the study of Curtis et al. However, the follow-up GWAS with the 
largest sample sizes has not replicated this result13. Our study is the first conducted with individuals of Chinese 
Han ancestry to replicate the significant association of rs17645023 and SCZ. The finding in this study of the 
association between rs17645023 and SCZ has generated more questions than answers. As an intergenic SNP, it is 
difficult to map to a specific gene. In the study conducted by Curtis et al., rs17645023 was originally mapped to 
CACNG5, which is located 35 kb upstream from rs17645023. However, rs17645023 was also shown to be located 
approximately 44 kb upstream of CACNG4. It should not be assumed that this SNP is mapped to CACNG5 simply 
because it is located 9 kb closer than CACNG4. Fortunately, we now have more efficient bioinformatics tools and 
large-scale datasets (such as ENCODE). A bioinformatics analyses indicates that rs17645023 may affect the bind-
ing of the transcription factor CEBPB, suggesting that it is more reasonable to map this SNP to CACNG4, which 
is located downstream of the SNP.
Our haplotype-based analyses provided some clues to a potential association between CACNG8 and SCZ. To 
our knowledge, our study is the first to identify such a link. Although more studies are still needed to illustrate the 
specific effects of the CACNG8 gene on SCZ, a general discussion based on previous literature might be helpful to 
provide some clues. Rouach et al. studied the role of the Cacng8 protein in mice38. The authors found that mice 
deficient in the Cacng8 protein showed a differential regulation of functional α -amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPA receptor) in the extrasynaptic and synaptic pools. These findings indi-
cate that the Cacng8 protein may act as a critical protein for AMPA receptor expression and distribution in the 
hippocampus of mice. Interestingly, multiple studies have demonstrated that SCZ is related to brain region- and 
subunit-specific abnormalities in the expression of the AMPA receptor subunits39,40. In this sense, the CACNG8 
gene may affect the onset and development of SCZ through its effect on the expression and distribution of AMPA 
receptors.
Numerous studies have indicated that the epistasis effects can account for a large portion of the genetic effects 
for a complex disorder41–43. Early studies have provided statistical evidence for the epistasis between DISC1, CIT 
and NDEL1 and risk for SCZ44. Our two-way interaction analyses identified a significant SNP pair (rs192808- 
rs2048137, CACNG6-CACNG5). Despite the problems associated with multiple comparisons, the result of the 
permutation analysis (Pperm < 0.001) indicates that this signal cannot be attributed to chance. Nevertheless, the 
identification of a statistical epistasis among susceptible genes does not illustrate their underlying biological inter-
actions. As discussed above, CACNG5 was reported to be associated with SCZ in the study of Curtis et al.37, 
although it is unlikely the SNP rs17645023 maps to CACNG5. CACNG6 was previously reported to be associated 
with aspirin-intolerance in asthmatics in a Korean population45, and to date, no evidence has shown a potential 
link between CACNG6 and SCZ. Based on sequence homology and chromosomal linkage, the calcium channel γ 
subunits can be divided into three clusters: (γ 1,γ 6), (γ 5,γ 7) and (γ 2,γ 3,γ 4,γ 8)24. Therefore, the proteins encoded by 
CACNG5 and CACNG6 belong to different clusters of calcium channel γ subunits. Our bioinformatics analysis 
SNPS HAPLOTYPE F_A F_U CHISQ P
rs2048137-rs740805 OMNIBUS – – 1.607 0.448
GA 0.156 0.151 0.576 0.448
TA 0.268 0.276 1.388 0.239
TG 0.577 0.573 0.261 0.609
rs11659136-rs2286678 OMNIBUS – – 0.992 0.609
TG 0.259 0.253 0.587 0.444
CG 0.192 0.189 0.155 0.694
CA 0.550 0.558 0.965 0.326
rs11079671-rs4791016 OMNIBUS – – 1.303 0.521
GA 0.146 0.142 0.425 0.514
GC 0.083 0.079 0.725 0.395
CC 0.771 0.779 1.218 0.270
rs10420331-rs11084307 OMNIBUS – – 26.960 1.40 × 10−6
GT 0.376 0.386 1.548 0.213
AT 0.058 0.041 26.830 2.22 × 10−7
AC 0.566 0.574 0.906 0.341
Table 2. The results of a haplotype-based analysis. The significant results are highlighted in bold.
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using STRING found no direct evidence for the protein-protein interaction between the two different proteins 
encoded by CACNG5 and CACNG6. More studies are still needed to clarify the underlying biological interactions 
between the two proteins.
A major strength of our study is the candidate gene-based study design. Although a GWAS has a much larger 
genomic coverage, its results are susceptible to many type I errors. Additionally, applying the Bonferroni cor-
rection for the inflated type I errors will result in the loss of several signals with moderate effects. Our candidate 
gene-based design avoids this disadvantage by focusing on a couple of functionally related genes and controlling 
the number of genotyped markers to a reasonable level. Another strength of our study is that we have a much 
larger sample size (~10,000) in comparison to other similar studies. A power analysis showed that this sample size 
enables us to detect moderate genetic effects with ORs as small as 1.15. There are also several limitations of our 
study. The coverage of our genotyped SNPs is a major disadvantage of this study. In the present study, we geno-
typed only 35 SNPs (~4 SNPs per gene) within the calcium channel γ subunit gene family (CACNG1-CACNG8). 
Therefore, it is doubtful that our study is complete because potential significant signals may be missed due to the 
low coverage of our genetic markers. Although this limitation can be partly compensated through imputation 
analyses, our results should be confirmed in other cohorts and populations using high-density marker panels 
and large-scale genotyping to provide more confident evidence for the association of the SNPs with SCZ. In 
addition to the low coverage of genetic markers, the population stratification might be another limitation for our 
study. Unlike large-scale genetic studies, which enable researchers using high-density marker data to apply some 
statistical intensity methods (e.g., genomic control, PCA) to correct the underlying population stratifications, we 
cannot perform any direct controls in our study because of the limited number of genotyped markers. Another 
limitation of this study is that in order to reduce the genotyping costs and maximize the genetic information, 
Figure 1. Epistasis analysis results for rs192808 and rs2048137. (a) Average percentage of SCZ patients for 
different genotypes of SNP rs2048137. (b) Average percentage of SCZ patients for different genotypes of SNP 
rs192808. c. Average percentage of SCZ patients for the combination genotype of rs192808 and rs2048137. The 
average percentage of SCZ patients in all samples is indicated with the dotted line. The significant P values based 
on the additive model are shown in each plot.
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all SNPs genotyped in our study are tag SNPs in the LD blocks, and very few of them can be constructed into 
LD blocks again. As a result of this strategy, it is difficult to carry out haplotype-based analysis for the SNP of 
rs17645023 (due to the difficulties of constructing LD blocks), and we lost the chance to further validate our sig-
nificant signal from a single-marker analysis in the haplotype-based analysis. In addition, although several quality 
control processes have been applied during the sample collection process to ensure the uniformity of the genetic 
background of our samples, this does not guarantee the complete removal of the confounding effects of differ-
ent sub-populations especially considering the genetic diversity of the Han Chinese population. Therefore, our 
findings should be considered preliminary, and additional follow-up studies are required, including high-density 
mapping and targeted deep sequencing to provide additional information beyond studies focused on common 
variants and to undercover fundamental characteristics of any potential associations with SCZ. In addition, in 
addition to the calcium channel γ gene family, recent studies have also identified several susceptible genes for SCZ 
Figure 2. Regional association plot constructed based on the 1 Mb region around SNP rs17645023.  
The genotyped SNPs are indicated as squares and the imputed SNPs are indicated as circles. The most significant 
genotyped SNP was chosen as a reference SNP in plots (rs17645023).
Figure 3. The forest plot of the meta-analysis for SNP rs17645023 using five PGC GWAS datasets. 
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within the α and β gene families. Systematic studies focusing on all the calcium channel gene families are needed 
to illustrate the biomedical and the biological significance of these genes on SCZ.
In summary, our results indicated that CACNG4, CACNG5, CACNG6 and CACNG8 might be genes that con-
tribute to the risk of SCZ. The statistical epistasis identified between CACNG5 and CACNG6 suggests that there 
is an underlying biological interaction between the two genes. However, more research is still needed to confirm 
our findings and to clarify the pathological mechanisms of the functional role of the calcium channel γ subunits 
gene family in SCZ and to eventually confer changes in clinical practice.
References
1. Sullivan, P. F., Daly, M. J. & O’Donovan, M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. 
Nat Rev Genet 13, 537–551 (2012).
2. Owen, M. J. Implications of genetic findings for understanding schizophrenia. Schizophrenia Bull 38, 904–907 (2012).
3. Chen, G., Guan, F., Lin, H., Li, L. & Fu, D. Genetic analysis of common variants in the HDAC2 gene with schizophrenia susceptibility 
in Han Chinese. J Hum Genet 60, 479–484 (2015).
4. Gejman, P. V., Sanders, A. R. & Kendler, K. S. Genetics of schizophrenia: new findings and challenges. Annu Rev Genomics Hum 
Genet 12, 121–144 (2011).
5. McGrath, J. J., Mortensen, P. B., Visscher, P. M. & Wray, N. R. Where GWAS and epidemiology meet: opportunities for the 
simultaneous study of genetic and environmental risk factors in schizophrenia. Schizophrenia Bull 39, 955–959 (2013).
6. O’donovan, M. C. et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 
40, 1053–1055 (2008).
7. Purcell, S. M. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 
(2009).
8. Shi, J. et al. Common variants on chromosome 6p22. 1 are associated with schizophrenia. Nature 460, 753–757 (2009).
9. Stefansson, H. et al. Common variants conferring risk of schizophrenia. Nature 460, 744–747 (2009).
10. Yue, W. H. et al. Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11. 2. Nat 
Genet 43, 1228–1231 (2011).
11. Schizophrenia Psychiatric Genome-Wide Association Study Consortium. Genome-wide association study identifies five new 
schizophrenia loci. Nat Genet 43, 969–976 (2011).
12. Ripke, S. et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45, 1150–1159 (2013).
13. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated 
genetic loci. Nature 511, 421–427 (2014).
14. Ozomaro, U., Wahlestedt, C. & Nemeroff, C. B. Personalized medicine in psychiatry: problems and promises. BMC Med 11, 132 
(2013).
15. Burmeister, M., McInnis, M. G. & Zöllner, S. Psychiatric genetics: progress amid controversy. Nat Rev Genet 9, 527–540 (2008).
16. Johnson, A. D. & O’Donnell, C. J. An open access database of genome-wide association results. BMC Med Genet 10, 6 (2009).
17. Guan, F. et al. Evaluation of genetic susceptibility of common variants in CACNA1D with schizophrenia in Han Chinese. Sci Rep 5 
(2015).
18. Moosmang, S. et al. Role of hippocampal Cav1. 2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial 
memory. J Neurosci 25, 9883–9892 (2005).
19. Guan, F. et al. MIR137 gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese. 
Schizophr Res 152, 97–104 (2014).
20. Bigos, K. L. et al. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch Gen Psychiat 67, 939–945 
(2010).
21. Erk, S. et al. Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch Gen Psychiat 67, 803–811 (2010).
22. Thimm, M. et al. Effects of a CACNA1C genotype on attention networks in healthy individuals. Psychol Med 41, 1551–1561 (2011).
23. Burgess, D. L., Gefrides, L. A., Foreman, P. J. & Noebels, J. L. A cluster of three novel Ca2+ channel γ subunit genes on chromosome 
19q13. 4: evolution and expression profile of the γ subunit gene family. Genomics 71, 339–350 (2001).
24. Chen, R. S., Deng, T.-C., Garcia, T., Sellers, Z. M. & Best, P. M. Calcium channel γ subunits: a functionally diverse protein family. Cell 
Biochem Biophys 47, 178–186 (2007).
Figure 4. (A) The protein-protein interactions of CACNG5. (B) The protein-protein interactions of CACNG6.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:24914 | DOI: 10.1038/srep24914
25. Wilson, G. M. et al. DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in 
glutamate signaling. Hum Mol Genet 15, 743–749 (2006).
26. Liu, Y. L. et al. RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-
deficit in sustained attention and executive function. Biol Psychiatry 64, 789–796 (2008).
27. Spitzer, N. C. Electrical activity in early neuronal development. Nature 444, 707–712 (2006).
28. Zoladz, P. R. et al. Differential expression of molecular markers of synaptic plasticity in the hippocampus, prefrontal cortex, and 
amygdala in response to spatial learning, predator exposure, and stress-nduced amnesia. Hippocampus 22, 577–589 (2012).
29. Purcell, S., Cherny, S. S. & Sham, P. C. Genetic Power Calculator: design of linkage and association genetic mapping studies of 
complex traits. Bioinformatics 19, 149–150 (2003).
30. Gabriel, S. B. et al. The structure of haplotype blocks in the human genome. Science 296(5576), 2225–2229 (2002).
31. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 
559–575 (2007).
32. Ripley, B. D. The R project in statistical computing. MSOR Connections 1, 23–25 (2001).
33. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide 
association studies through pre-phasing. Nat Genet 44, 955–959 (2012).
34. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by 
imputation of genotypes. Nat Genet 39, 906–913 (2007).
35. Schwarzer, G. meta: General Package for Meta-Analysis. R package version 4.3-1. http://CRAN.R-project.org/package= meta 
(2015).
36. The ENCODE (ENCyclopedia of DNA elements) project. The ENCODE (ENCyclopedia of DNA elements) project. Science 306, 
636–640 (2004).
37. Curtis, D. et al. Case-case genome wide association analysis reveals markers differentially associated with schizophrenia and bipolar 
disorder and implicates calcium channel genes. Psychiat Genet 21, 1 (2011).
38. Rouach, N. et al. TARP γ -8 controls hippocampal AMPA receptor number, distribution and synaptic plasticity. Nat Neurosci 8, 
1525–1533 (2005).
39. Tucholski, J. et al. Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia. Schizophr Res 146, 
177–183 (2013).
40. Drummond, J. B., Tucholski, J., Haroutunian, V. & Meador-Woodruff, J. H. Transmembrane AMPA receptor regulatory protein 
(TARP) dysregulation in anterior cingulate cortex in schizophrenia. Schizophr Res 147, 32–38 (2013).
41. Bell, J. T. et al. Genome-ide Association Scan Allowing for Epistasis in Type 2 Diabetes. Ann Hum Genet 75, 10–19 (2011).
42. Yi, N. et al. Characterization of epistasis influencing complex spontaneous obesity in the BSB model. Genetics 167, 399–409 (2004).
43. Wei, W. H., Hemani, G. & Haley, C. S. Detecting epistasis in human complex traits. Nat Rev Genet 15, 722–733 (2014).
44. Nicodemus, K. K. et al. Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological 
validation with functional neuroimaging. Hum Genet 127, 441–452 (2010).
45. Lee, J. S. et al. Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population. BMC Med Genet 
11, 138 (2010).
Acknowledgements
This research was supported by and National Natural Science Foundation of China (No. 81401563, 81373253 and 
81273351), Shaanxi Province Natural Science Foundation (No. 2015JQ8306), and Ph.D. Programs Foundation 
of Ministry of Education of China (No. 2013021120078) and Shaanxi Key Project on Science and Technology 
(2014K11-02-03-05). The funding sources had no role in the design of this study, the collection, analysis and 
interpretation of data, the writing of the report, or the decision to submit the paper for publication.
Author Contributions
Authors F.G. and Li.T. conceived and designed the study. Li.L and G.C. carried out the computational analyses 
and candidate SNPs selection. X.L., W.H. and H.L. conducted subject screening. F.G. and T.Z. performed the 
statistical analysis of the genotype and haplotype data. G.F. and T.Z. wrote the first draft of the paper, and T.L. 
revised the current paper. W.H. and H.L. recruited, diagnosed, and gathered patients. L.L and G.C. contributed to 
the collection and preparation of control DNA samples.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Guan, F. et al. Evaluation of voltage-dependent calcium channel γ gene families 
identified several novel potential susceptible genes to schizophrenia. Sci. Rep. 6, 24914; doi: 10.1038/srep24914 
(2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
